• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Species Isolation from Hospitalized Patients with COVID-19-A Retrospective Study.对新冠肺炎住院患者进行的物种分离——一项回顾性研究
Diagnostics (Basel). 2022 Dec 6;12(12):3065. doi: 10.3390/diagnostics12123065.
2
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.住院 COVID-19 合并念珠菌属感染患者的危险因素和临床结局评估:分离株的种属分布和抗真菌药敏模式。
Mycopathologia. 2023 Apr;188(1-2):9-20. doi: 10.1007/s11046-022-00694-x. Epub 2022 Dec 10.
3
Isolation Frequency Characteristics of Candida Species from Clinical Specimens.临床标本中念珠菌属的分离频率特征
Mycobiology. 2016 Jun;44(2):99-104. doi: 10.5941/MYCO.2016.44.2.99. Epub 2016 Jun 30.
4
Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia.COVID-19 肺炎重症患者中假丝酵母菌呼吸道定植和急性肺部感染的临床影响。
Microb Pathog. 2022 May;166:105520. doi: 10.1016/j.micpath.2022.105520. Epub 2022 Apr 9.
5
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染:英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
6
[Determination of Candida colonization and Candida score in patients in anesthesia intensive care unit].[麻醉重症监护病房患者念珠菌定植及念珠菌评分的测定]
Mikrobiyol Bul. 2016 Jul;50(3):438-48. doi: 10.5578/mb.27685.
7
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
8
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.风湿性疾病患者 COVID-19 疾病严重程度的决定因素。
Clin Rheumatol. 2020 Sep;39(9):2789-2796. doi: 10.1007/s10067-020-05301-2. Epub 2020 Jul 27.
9
Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.基于人群的培养确诊念珠菌血症主动监测-四个地点,美国,2012-2016 年。
MMWR Surveill Summ. 2019 Sep 27;68(8):1-15. doi: 10.15585/mmwr.ss6808a1.
10
High prevalence of asymptomatic nosocomial candiduria due to among hospitalized patients with heart failure: a matter of some concern?心力衰竭住院患者中由……引起的无症状医院念珠菌尿症患病率高:这是一个值得关注的问题吗?
Curr Med Mycol. 2020 Dec;6(4):1-8. doi: 10.18502/cmm.6.4.5327.

引用本文的文献

1
fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023.2021 年至 2023 年希腊一家三级保健教学医院的真菌血症暴发和泛棘白菌素耐药分离株的出现。
Euro Surveill. 2024 Nov;29(45). doi: 10.2807/1560-7917.ES.2024.29.45.2400128.
2
Candidemia Following Severe COVID-19 in Hospitalised and Critical Ill Patients: A Systematic Review and Meta-Analysis.COVID-19 住院和重症患者并发念珠菌血症:系统评价和荟萃分析。
Mycoses. 2024 Oct;67(10):e13798. doi: 10.1111/myc.13798.
3
Increase in candidemia cases and emergence of fluconazole-resistant and isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023.COVID-19 大流行期间,希腊一家三级保健教学医院的念珠菌血症病例增加,以及氟康唑耐药和 分离株的出现,2020 年至 2023 年。
Euro Surveill. 2024 Jul;29(29). doi: 10.2807/1560-7917.ES.2024.29.29.2300661.
4
The characteristics of microbiome in the upper respiratory tract of COVID-19 patients.新型冠状病毒肺炎患者上呼吸道微生物群的特征
BMC Microbiol. 2024 Apr 24;24(1):138. doi: 10.1186/s12866-024-03281-w.

本文引用的文献

1
Candida auris outbreak at a tertiary care hospital during the COVID-19 pandemic.COVID-19 大流行期间一家三级保健医院发生的耳念珠菌病暴发。
Am J Infect Control. 2024 Aug;52(8):878-883. doi: 10.1016/j.ajic.2024.03.012. Epub 2024 Mar 25.
2
COVID-19-associated fungal infections.COVID-19 相关真菌感染。
Nat Microbiol. 2022 Aug;7(8):1127-1140. doi: 10.1038/s41564-022-01172-2. Epub 2022 Aug 2.
3
Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era.新冠疫情大流行时代前后重症监护病房念珠菌血症及氟康唑耐药性的流行病学研究
Antibiotics (Basel). 2022 Jun 4;11(6):771. doi: 10.3390/antibiotics11060771.
4
COVID-19 and : A Case-Control Study from a Tertiary Care Center in Lebanon.新冠病毒病与:黎巴嫩一家三级医疗中心的病例对照研究
Microorganisms. 2022 May 11;10(5):1011. doi: 10.3390/microorganisms10051011.
5
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections.COVID-19 对监测侵袭性真菌感染的全球监测计划中收集的分离株的抗真菌药敏谱的影响。
Med Mycol. 2022 May 6;60(5). doi: 10.1093/mmy/myac028.
6
Candida Score: a Predictor of Mortality in Patients with Candidemia.念珠菌评分:念珠菌血症患者死亡率的预测指标。
J Assoc Physicians India. 2022 Feb;70(2):11-12.
7
Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.COVID-19 相关毛霉菌病的临床特征和死亡率:系统评价和荟萃分析。
Mycopathologia. 2022 Jun;187(2-3):271-289. doi: 10.1007/s11046-022-00627-8. Epub 2022 Mar 21.
8
COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies.新型冠状病毒肺炎相关念珠菌病:可能的发病机制、易感因素及预防策略
Curr Microbiol. 2022 Mar 14;79(5):127. doi: 10.1007/s00284-022-02824-6.
9
Worldwide prevalence of fungal coinfections among COVID-19 patients: a comprehensive systematic review and meta-analysis.新冠病毒疾病患者中真菌合并感染的全球患病率:一项全面的系统综述与荟萃分析。
Osong Public Health Res Perspect. 2022 Feb;13(1):15-23. doi: 10.24171/j.phrp.2021.0293. Epub 2022 Feb 8.
10
10th Trends in Medical Mycology Held on 8 to 11 October 2021, Aberdeen, Scotland, Organized by the European Confederation of Medical Mycology (ECMM).第十届医学真菌学趋势会议于2021年10月8日至11日在苏格兰阿伯丁举行,由欧洲医学真菌学联合会(ECMM)主办。
J Fungi (Basel). 2021 Oct 28;7(11):916. doi: 10.3390/jof7110916.

对新冠肺炎住院患者进行的物种分离——一项回顾性研究

Species Isolation from Hospitalized Patients with COVID-19-A Retrospective Study.

作者信息

Ioannou Petros, Kofteridis Diamantis P, Alexakis Konstantinos, Koutserimpas Christos, Papakitsou Ioanna, Maraki Sofia, Samonis George

机构信息

COVID-19 Department, University Hospital of Heraklion, 71500 Heraklion, Greece.

Department of Orthopaedics and Traumatology, "251" Hellenic Air Force General Hospital of Athens, 11525 Athens, Greece.

出版信息

Diagnostics (Basel). 2022 Dec 6;12(12):3065. doi: 10.3390/diagnostics12123065.

DOI:10.3390/diagnostics12123065
PMID:36553072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9776868/
Abstract

Coronavirus disease 2019 (COVID-19), a disease characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has so far led to hundreds of millions of infections and millions of deaths. Fungal infections are known to complicate COVID-19 patients and are associated with significant morbidity and mortality. The aim of this study was to assess the incidence of positive cultures for spp. among patients hospitalized with COVID-19, describe their characteristics and identify factors associated with overall mortality in this patient population. Hospitalized COVID-19 patients with spp. isolation were retrospectively assessed and their clinical, laboratory and microbiological characteristics were assessed and evaluated. In total, 69 patients with COVID-19 had a positive culture for spp., representing a rate of 4.5% among all hospitalized COVID-19 patients. Their median age was 78 years (IQR 67-85 years) and 44.9% were male. Hospitalized patients with COVID-19 and spp. isolation who died were older, were more likely to have a diagnosis of dementia, and had higher Charlson comorbidity index, higher score and higher 4C score. score was identified with a multivariate logistic regression analysis model to be independently associated with mortality. The most commonly identified species was , followed by and and the most common source was the urine, even though in most cases the positive culture was not associated with a true infection. Thus, score may be used in COVID-19 patients with isolation of spp. from different body specimens for mortality risk stratification.

摘要

2019冠状病毒病(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的疾病,迄今为止已导致数亿人感染和数百万人死亡。已知真菌感染会使COVID-19患者病情复杂化,并与显著的发病率和死亡率相关。本研究的目的是评估COVID-19住院患者中[具体真菌种类]培养阳性的发生率,描述其特征,并确定该患者群体中与总体死亡率相关的因素。对COVID-19住院且有[具体真菌种类]分离的患者进行回顾性评估,并对其临床、实验室和微生物学特征进行评估和评价。共有69例COVID-19患者[具体真菌种类]培养呈阳性,占所有住院COVID-19患者的4.5%。他们的中位年龄为78岁(四分位间距67 - 85岁),44.9%为男性。COVID-19住院且有[具体真菌种类]分离的死亡患者年龄更大,更有可能被诊断为痴呆,且Charlson合并症指数更高、[具体评分]更高和4C评分更高。通过多因素逻辑回归分析模型确定[具体评分]与死亡率独立相关。最常鉴定出的[真菌种类]是[具体名称1],其次是[具体名称2]和[具体名称3],最常见的来源是尿液,尽管在大多数情况下培养阳性与真正的感染无关。因此,[具体评分]可用于对从不同身体标本中分离出[具体真菌种类]的COVID-19患者进行死亡风险分层。